Legalize / United Kingdom / Statutory-Instrument

The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019

Type Statutory-Instrument

Publication 2019-03-20

Last updated 2023-12-31

State In force

Department King's Printer of Acts of Parliament

Source legislation.gov.uk

PDF Download

articles Not indexed

Reform history JSON API

(vii) in point 3.2(g), for “in a Member State” substitute “ by at least one competent authority ”;

(viii) in point 3.3—

(aa) for “Member State” substitute “ competent authority ”;

(bb) after “its” insert “ constituent ”;

(ix) omit point 6;

(b) in Part A—

(i) in points 1.4.3 and 4.4, for “Union legislation” substitute “ retained EU law ”;

(ii) in point 4.5.2, in the first paragraph, for “Directive 94/67/EC of the Council” substitute “ the EU-derived domestic legislation which transposed Directive 2010/75/EU of the European Parliament and of the Council on industrial emissions (integrated pollution prevention and control) ”;

(iii) in points 7.1.7 and 7.1.8, omit “national”;

(iv) in points 7.2.1.2 and 7.2.3.2, after “in accordance with” in the second place it occurs insert “ the EU-derived domestic legislation which transposed ”;

(v) in point 9.1.1.2.2, in the fourth paragraph—

(aa) omit the words from “being included” to “introduction”;

(bb) omit “national”;

(vi) in points 9.1.2.3 and 9.2.3, omit “national”;

(vii) in point 9.2.4.1, in the second paragraph, omit “EU”;

(viii) in point 9.2.4.2, omit “national”;

(ix) in point 9.2.5—

(aa) in the second paragraph, omit “EU”;

(bb) in the fourth paragraph, omit “national”;

(x) in points 9.4, 10.1.3, 10.2.2, 10.4.2.2, 10.6.3 and 10.6.4, omit “national” in each place it occurs;

(i) in point 1.1, in the second paragraph, for “ the Member State in which the authorisation is being sought” substitute “ Great Britain ”;

(ii) in point 1.4(ii), for “Directive 1999/45/EC of the European Parliament and of the Council” substitute “ Regulation (EC) No 1272/2008 ”;

(iii) in point 6.5, in the eighth paragraph—

(aa) for “Member State” in the first place it occurs substitute “ competent authority ”;

(bb) for “territory of this Member State” substitute “ constituent territory of that competent authority ”;

(iv) in points 7.1, 7.1.1 and 7.1.3, omit “Directive 1999/45/EC or”;

(v) in Section 11, in the first paragraph, omit “of the Member States”.

PART 3 — Transferred functions from Directive 2009/128/EC of the European Parliament and of the Council establishing a framework for Community action to achieve the sustainable use of pesticides

Power to update references to Annexes to Directive 2009/128/EC in light of scientific and technical progress

23

(1) The appropriate authority may, by regulations, make provision for a reference to a relevant Annex to Directive 2009/128/EC of the European Parliament and of the Council establishing a framework for Community action to achieve the sustainable use of pesticides in any enactment to be read as a reference to that Annex as modified by the regulations.

(2) But the appropriate authority may exercise the power in paragraph (1) only to the extent that the appropriate authority considers that it is appropriate to do so as a result of scientific and technical progress.

(3) The appropriate authority may, by regulations, amend any enactment which makes provision corresponding to that made by a relevant Annex to Directive 2009/128/EC for the purposes of ensuring that the provision made by the enactment continues to correspond to that made by the Annex as modified by regulations made under paragraph (1).

(4) The relevant Annexes to Directive 2009/128/EC are—

(a) Annex 1 (training subjects referred to in Article 5 of Directive 2009/128/EC);

(b) Annex 2 (health and safety and environmental requirements relating to the inspection of pesticide application equipment);

(d) Annex 4 (harmonised risk indicators).

(5) In this regulation, “the appropriate authority” means—

(a) for regulations applying in relation to England, the Secretary of State;

(b) for regulations applying in relation to Wales, the Welsh Ministers;

(d) for regulations applying in relation to Northern Ireland, the Department.

(6) But the appropriate authority is the Secretary of State if consent is given by—

(a) for regulations applying in relation to Wales, the Welsh Ministers;

(b) for regulations applying in relation to Scotland, the Scottish Ministers;

(7) In this regulation, “the Department” means the Department of Agriculture, Environment and Rural Affairs in Northern Ireland.

Regulations

24

(1) Regulations made by the Secretary of State or Welsh Ministers under regulation 23 are to be made by statutory instrument.

(2) For regulations made under regulation 23 by the Scottish Ministers, see section 27 of the Interpretation and Legislative Reform (Scotland) Act 2010.

(3) Any power to make regulations conferred on the Department under regulation 23 is exercisable by statutory rule for the purposes of the Statutory Rules (Northern Ireland) Order 1979.

(4) A statutory instrument containing regulations made by the Secretary of State under regulation 23 is subject to annulment in pursuance of a resolution of either House of Parliament.

(5) A statutory instrument containing regulations made by the Welsh Ministers under regulation 23 is subject to annulment in pursuance of a resolution of the National Assembly for Wales.

(6) Regulations made by the Scottish Ministers under regulation 23 are subject to the negative procedure (see section 28 of the Interpretation and Legislative Reform (Scotland) Act 2010).

(7) Regulations made by the Department under regulation 23 are subject to negative resolution within the meaning of section 41(6) of the Interpretation Act (Northern Ireland) 1954.

(8) Such regulations may—

(a) contain consequential, incidental, supplementary, transitional or saving provision (including provision amending, repealing or revoking enactments);

(b) make different provision for different purposes.

(9) In this regulation, “the Department” has the meaning given in regulation 23(7).

PART 4 — Consequential amendments, savings, transitional provisions and revocations

Amendment of Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency

25

In Article 15 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, for paragraph 1 substitute—

(1) The following are regarded as being registered, and the registration as completed, for manufacture or import for the use as a plant protection product and therefore as fulfilling the requirements of Chapters 1 and 5 of this Title— (a) active substances manufactured or imported for use in plant protection products only and included in the approvals register in relation to at least one constituent territory; (b) co-formulants manufactured or imported for use in plant protection products only and not included in the unacceptable co-formulants register in relation to the whole of the UK; (c) any substance in relation to which the applicant has been notified in accordance with Article 9(3) of Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market. (1A) In paragraph 1— (a) in point (a)— (i) “approvals register” means the register maintained in accordance with Article 27A of Regulation (EC) No 1107/2009; (ii) “constituent territory” has the meaning given by Article 3A of Regulation (EC) No 1107/2009; (b) in point (b), “unacceptable co-formulants register” means the register maintained in accordance with Article 27B of Regulation (EC) No 1107/2009.

Amendment of the Plant Protection Products Regulations 2011

26

(1) The Plant Protection Products Regulations 2011 are amended as follows.

(2) In regulation 10—

(a) for paragraph (1) substitute—

(1) A person must not place on the market or use in a constituent territory (“the relevant constituent territory”) seeds treated with a plant protection product, other than an appropriate plant protection product, or cause or permit another person to do so. (1A) Paragraph (1) does not apply in relation to seeds which a competent authority must not prohibit in accordance with Article 49 as read with paragraph 14 of Schedule 1 to the Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019.

(b) in paragraph (3), for the words from “plant” to the end, substitute “ an appropriate plant protection product, or seeds which a competent authority must not prohibit in accordance with Article 49 as read with paragraph 14 of Schedule 1 to the Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019. ”;

(4) In this regulation, “appropriate plant protection product” means— (a) a plant protection product authorised in relation to the relevant constituent territory for use on such seeds, or (b) a plant protection product authorised in relation to another constituent territory for use on such seeds, where— (i) every active substance, low-risk active substance or candidate for substitution in that product is approved in relation to the relevant constituent territory, and (ii) every co-formulant in that product does not appear on the unacceptable co-formulants register in relation to the relevant constituent territory.

Saving: the Plant Protection Products Regulations 2011

27

(1) The amendments made to regulation 10 of the Plant Protection Products Regulations 2011 by regulation 26 do not affect—

(a) any obligation or liability acquired, accrued or incurred before IP completion day;

(b) any penalty, forfeiture or punishment incurred in respect of any offence committed before IP completion day; or

(2) Any penalty, forfeiture or punishment referred to in paragraph (1)(b) may be imposed as if regulation 26 had not come into force.

(3) Any investigation, legal proceeding or remedy referred to in paragraph (1)(c) may be instituted, continued or enforced as if regulation 26 had not come into force.

Transitional provisions

28

Schedule 1 has effect.

Revocation of retained EU legislation and saving

29

(1) The retained EU legislation in Schedule 2 is revoked.

(2) Despite paragraph (1), a grace period contained within an EU instrument listed in Schedule 2 which expires after IP completion day continues to have effect, and is treated as if it had been set by each competent authority in relation to its constituent territory in accordance with Article 21(6)(b) of Regulation (EC) No 1107/2009.

Revocation: EEA agreement

30

In Annex 2 to the EEA agreement, in Chapter 15—

(a) omit points 12g and 12k;

(b) omit the adaptations in point 13;

(d) omit the adaptations in point 13e;

(e) omit points 13g to 13zzzzzzzzn.

SCHEDULE 1 — Transitional provisions

PART 1 — Interpretation

Interpretation

1

In this Schedule—

“Regulation (EU) No 844/2012” means Commission Implementing Regulation (EU) No 844/2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market;

“plant protection product” has the meaning given by Article 2(1) of Regulation (EC) No 1107/2009.

PART 2 — Active substances, basic substances, low-risk active substances and candidates for substitution

Existing approvals of active substances, etc.: general

2

(1) An active substance, basic substance, low-risk active substance or candidate for substitution which is set out in an entry in a table in the Annex is deemed to have been approved by each competent authority in relation to its constituent territory under Article 13 of Regulation (EC) No 1107/2009 in accordance with sub-paragraphs 2(3) and 2(4).

(2) Sub-paragraph (1) does not apply to an entry in a table in the Annex for an approval which expired before IP completion day.

(3) An active substance, basic substance, low-risk active substance or candidate for substitution to which sub-paragraph (1) applies is deemed to have been approved—

(a) from the date of approval stated in the relevant entry in the Annex;

(b) until the existing expiration date, except—

(i) for a basic substance, or

(ii) as provided for in sub-paragraph (4);

(c) subject to the specific provisions stated in the relevant entry in the Annex as modified in accordance with paragraph 3.

(4) Where the existing expiration date for an approval is on or before the date three years after the day after the day on which IP completion day falls , approval is taken instead to expire at the end of a period of three years beginning with the existing expiration date.

(5) In this paragraph—

“the Annex” means the Annex to Commission Implementing Regulation (EU) No 540/2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances as it had effect immediately before IP completion day ;

“existing expiration date” means the date for the expiration of approval stated in the relevant entry in the Annex.

Existing approvals: Annex modifications

3

(1) For the purposes of paragraph 2(3)(c), the Annex is modified in accordance with this paragraph.

(2) In the Annex—

(a) a reference to Member States is to be read as a reference to competent authorities;

(b) a reference to Article 29(6) of Regulation (EC) No 1107/2009 is to be read as a reference to Article 29(6)(a) of that Regulation;

(c) a requirement on a notifier to submit, or on a member State to ensure that a notifier submits, further studies, data or information to the Commission, one or more member States or the Authority within a period of time which has expired before IP completion day is to be ignored;

(d) a requirement on member States to inform the Commission in accordance with Article 38 of Regulation (EC) No 1107/2009 is to be ignored;

(3) The entries in the table in Part A of the Annex are modified as follows—

(a) in entry 46 (Cyazofamid), in the seventh column, in the second paragraph, in the second sentence, the second indent is to be read as if “especially for Northern European regions” were omitted;

(b) in entry 173 (Difenoconazole), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The notifier must submit to each competent authority the information set out in point (d) within 2 years from the issuing of specific guidance.

(d) in entry 176 (Lenacil), in the seventh column, Part B is to be read as if, in the fourth paragraph, in the second sentence, for “the Commission” there were substituted “ each competent authority ”;

(e) in entry 210 (Abamectin), in the seventh column, in Part B, the fourth paragraph is to be read as if for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(f) in entry 211 (Epoxiconazole), in the seventh column, Part B is to be read as if, for the third paragraph there were substituted—

The notifier must submit to each competent authority further studies addressing the potential endocrine disrupting properties of epoxiconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, the issuing of test guidelines set by the competent authority.

(g) in entry 217 (Metazachlor), in the seventh column, Part B is to be read as if, in the fifth paragraph, for “the Commission” there were substituted “ each competent authority ”;

(h) in entry 268 (Tebuconazole), in the seventh column, Part B is to be read as if for the second paragraph there were substituted—

The notifier must submit to each competent authority further information addressing the potential endocrine disrupting properties of tebuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, the issuing of test guidelines set by the competent authority.

(i) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(j) in entry 282 (Chlorsulfuron), in the seventh column, Part B is to be read as if, in the fourth paragraph, for “the Commission” there were substituted “ each competent authority ”;

(k) in entry 284 (Dimethachlor), in the seventh column, Part B is to be read as if, in the fifth paragraph, for “the Commission” there were substituted “ each competent authority ”;

(l) in entry 289 (Triflusulfron), in the seventh column, Part B is to be read as if, in the third paragraph, for “the Commission” there were substituted “ each competent authority ”;

(m) in entry 307 (Sulfuryl fluoride), in the seventh column, Part B is to be read as if, in the fourth paragraph—

(i) for “the Commission, Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for “2017” there were substituted “ 2022 ”;

(n) in entry 315 (Fenbuconazole), in the seventh column, Part B is to be read as if, for the sixth paragraph there were substituted—

The notifier must submit to each competent authority further information addressing the potential endocrine disrupting properties of fenbuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, the issuing of test guidelines set by the competent authority.

(o) in entry 318 (Bromuconazole), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The notifier must submit to each competent authority further information addressing the potential endocrine disrupting properties of bromuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, the issuing of test guidelines set by the competent authority.

(p) in entry 327 (Oryzalin), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (4) within six months of notification of a decision classifying oryzalin.

(q) in entry 328 (Tau-fluvalinate), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority confirmatory information addressing the possible impact on the environment of the potential enantio-selective degradation in environmental matrices, within two years after the issuing of specific guidance.

(r) in entry 335 (Fluometuron), in the seventh column, Part B is to be read as if—

(i) in the third paragraph, in the words before point (a), for “the Commission” there were substituted “ each competent authority ”;

(ii) for the fourth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (d) within six months of notification of a decision classifying fluometuron.

(s) in entry 337 (Carboxin), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (h) within six months of notification of a decision classifying carboxin.

(t) in entry 338 (Cyproconazole), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (e) within two years of the issuing of specific guidance.

(u) in entry 344 (Diclofop), in the seventh column, Part B is to be read as if, for the fourth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (b) within two years of the issuing of a specific guidance document on evaluation of isomers mixtures.

(v) in entry 348 (Paclobutrazol), in the seventh column, Part B is to be read as if, for the fourth paragraph there were substituted—

The applicant must submit to each competent authority— (a) the information set out in point (4) within two years after the adoption of the OECD test guidelines on endocrine disruption, and (b) the information set out in point (5) within two years after the issuing of specific guidance.

(w) in entry 352 (Hexythiazox), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (d) within two years after the issuing of specific guidance.

(x) in entry 354 (Flurochloridone), in the seventh column, Part B is to be read as if—

(i) in the fourth paragraph, in the words before point (1), for “the Commission” there were substituted “ each competent authority ”;

(ii) for the fourth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (4) within two years after the adoption of the OECD test guidelines on endocrine disruption.

(4) The entries in the table in Part B of the Annex are modified as follows—

(a) in entry 7 (Sprioxamine), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (a) within two years after the issuing of specific guidance.

(b) in entry 10 (Tefluthrin), in the seventh column, Part B is to be read as if, for the fourth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the issuing of a specific guidance document on evaluation of isomers mixture.

(c) in entry 16 (Terbuthylazine), in the seventh column, Part B is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (4) within six months of the notification of the classification decision for terbuthylazine.

(d) in entry 19 (Acrinathrin), in the seventh column, Part B is to be read as if, for the fourth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (4) within two years after the issuing of specific guidance.

(e) in entry 20 (Prochloraz), in the seventh column, Part B is to be read as if, for the fourth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the adoption of the OECD test guidelines on endocrine disruption.

(f) in entry 48 (Sedaxane), in the seventh column, Part B is to be read as if for the sixth paragraph there were substituted—

The notifier must submit to each competent authority the relevant information within six months of the notification of the classification decision for sedaxane.

(g) in entry 49 (Emamectin), the seventh column is to be read as if for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the relevant information within two years after the issuing of a specific guidance document on evaluation of isomers mixtures.

(h) in entry 51 (Fluopyram), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (2) within two years after the adoption of the OECD test guidelines on endocrine disruption.

(i) in entry 55 (Penflufen), in the seventh column, Part B is to be read as if in the fourth paragraph for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(j) in entry 57 (Penthiopyrad), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The notifier must submit to each competent authority the relevant information within six months of the notification of the classification decision for penthiopyrad.

(k) in entry 60 (Spirotetramat), the seventh column is to be read as if in the fourth paragraph—

(i) for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for “Community agreed test guidelines” there were substituted “ test guidelines set by the competent authority ”;

(l) in entry 67 (Spinetoram), the seventh column is to be read as if in the fifth paragraph, for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(m) in entry 69 (Amisulbrom), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (5) within two years after the adoption of OECD test guidelines on endocrine disruption.

(n) in entry 73 (Ipconazole), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority— (a) the information set out in point (c) of the fourth paragraph within two years after the issuing of a specific guidance document on evaluation of isomer mixtures, and (b) the information set out in point (d) of the fourth paragraph within two years after the adoption of OECD or national test guidelines on endocrine disruption.

(o) in entry 80 (Meptyldinocap), the seventh column is to be read as if , for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (b) within two years after the issuing of specific guidance.

(p) in entry 91 (Flupyradifurone), the seventh column is to be read as if , for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(q) in entry 97 (Pinoxaden), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The notifier must submit to each competent authority the relevant information within six months of the notification of the classification decision for pinoxaden.

(r) in entry 99 (Cyantraniliprole), the seventh column is to be read as if for the fourth paragraph there were substituted—

The applicant must submit to each competent authority confirmatory information as regards the effect of water treatment processes on the nature of residues present in surface and groundwater, when surface water or groundwater are abstracted for drinking water within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(s) in entry 100 (Isofetamid), the seventh column is to be read as if—

(i) in the fourth paragraph, in the words before point (1), for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(t) in entry 104 (Thifensulfuron-methyl), the seventh column is to be read as if—

(i) in the fourth paragraph, in the words before point (1), for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (4) within six months of the notification of the classification decision for thifensulfuron-methyl.

(u) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(v) in entry 107 (Iodosulfuron), the seventh column is to be read as if—

(i) in the fourth paragraph, in the words before point (1), for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (2) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(w) in entry 108 (Flazasulfuron) and entry 111 (Mesosulfuron), the seventh column is to be read as if for the fourth paragraph there were substituted—

The applicant must submit to each competent authority confirmatory information as regards the effect of water treatment processes on the nature of residues present in surface and groundwater within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(x) in entry 112 (Mesotrione), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(y) in entry 114 (Propoxycarbazone), the seventh column is to be read as if for the fourth paragraph there were substituted—

The applicant must submit to each competent authority confirmatory information as regards the effect of water treatment processes on the nature of residues present in drinking water within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(z) in entry 121 (Silthiofam), the seventh column is to be read as if—

(i) in the fourth paragraph, in the words before point 1, for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) in the fifth paragraph—

(aa) for “Commission” there were substituted “ competent authority ”;

(bb) for the words from “one year” to the end there were substituted “ six months of the notification of the classification decision for Silthiofam ”;

(aa) in entry 123 (Zoxamide), the seventh column is to be read as if, in the fourth paragraph—

(i) for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for “Commission” in the second place it appears there were substituted “ competent authority ”;

(bb) in entry 124 (Trifloxystrobin), the seventh column is to be read as if—

(i) for the fifth paragraph, there were substituted—

The applicant must submit to each competent authority the information set out in point (1) within six months of the notification of the classification decision for trifloxystrobin.

(ii) in the sixth paragraph, for “the Commission” there were substituted “ each competent authority ”;

(cc) in entry 125 (Carfentrazone-ethyl), the seventh column is to be read as if—

(i) for the fifth paragraph, there were substituted—

The applicant must submit to each competent authority the information set out in point (1) within six months of the notification of the classification decision for carfentrazone-ethyl.

(ii) in the sixth paragraph, for “the Commission” there were substituted “ each competent authority ”;

(dd) in entry 126 (Fenpicoxamid), the seventh column is to be read as if—

(i) in the fourth paragraph, in point 3, “, as amended by Commission Regulation (EU) 2018/605,” were omitted;

(ii) in the fifth paragraph—

(aa) for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(bb) for “Commission” in the second place it occurs there were substituted “ competent authority ”;

(ee) in entry 127 (Pethoxamid), in the seventh column, Part B is to be read as if—

(i) in the fourth paragraph, in the words before point 1, for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) in the fifth paragraph, for the words from “one year” to the end there were substituted “ six months of the notification of the classification decision for pethoxamid ”;

(iii) in the sixth paragraph, for “Commission” there were substituted “ competent authority ”;

(iv) in the seventh paragraph, the words from “in accordance with” to the end were omitted.

(ff) in entry 132 (Mefentrifluconazole), the seventh column is to be read as if—

(i) in the fourth paragraph, in the words before point 1, for “the Commission, the Member States and the Authority” there were substituted “each competent authority”;

(ii) in the fifth paragraph, “, by the Commission,” were omitted;

(gg) in entry 133 (flutianil), the seventh column is to be read as if—

(i) in the fourth paragraph, in the words before point 1, for “the Commission, the Member States and the Authority” there were substituted “each competent authority”;

(ii) in the fifth paragraph, “, from the Commission,” were omitted;

(hh) in entry 134 (Isoxaflutole), in the seventh column, the fourth paragraph is to be read as if—

(i) in the first sentence, for “the Commission, the Member States and the Authority” there were substituted “each competent authority”;

(ii) in the second sentence, “, by the Commission,” were omitted;

(ii) in entry 135 (carvone), the seventh column is to be read as if—

(i) in the fourth paragraph, for “the Commission, the Member States and the Authority” there were substituted “each competent authority”;

(ii) in the fifth paragraph, “, by the Commission,” were omitted.

(jj) in entry 137 (Dimethenamid-P), the seventh column is to be read as if, for the fourth and fifth paragraphs there were substituted—

The applicant must submit to each competent authority confirmatory information as regards the effect of water treatment processes on the nature of residues present in surface and groundwater, when surface water or ground water is abstracted for drinking water. The applicant must submit the requested information within two years from the date of publication of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(kk) in entry 139 (Florpyrauxifen-benzyl), the seventh column is to read as if, for the fourth paragraph there were substituted—

The applicant must submit to each competent authority an updated assessment of the information submitted and, where relevant, further information to confirm the absence of endocrine activity in accordance with points 3.6.5 and 3.8.2 of Annex 2 to Regulation (EC) No 1107/2009 by 24 July 2021.

(5) The entries in the table in Part E of the Annex are modified as follows—

(a) in entry 4 (Benzovindiflupyr), the seventh column is to be read as if, for the fifth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(b) in entry 7 (Pendimethalin), the seventh column is to be read as if—

(i) in the fifth paragraph, in the words before point (1), for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for the sixth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (2) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(i) in the fifth paragraph, in the words before point (1), for “the Commission, the Member States and the Authority” there were substituted “ each competent authority ”;

(ii) for the sixth paragraph there were substituted—

The applicant must submit to each competent authority the information set out in point (3) within two years after the issuing of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(d) in entry 11 (Methoxyfenozide), the seventh column is to be read as if, in the fifth paragraph, in the words before point 1, for “the Commission, the Member States and the Authority” there were substituted “each competent authority”.

(e) in entry 12 (Alpha-cypermethrin), the seventh column is to be read as if—

(i) in the third paragraph, in the words before point (1), for “the Commission, the Member States and the Authority” there were substituted “each competent authority”;

(ii) for the fourth paragraph there were substituted—

The applicant must submit the information requested in point (1) by 31 March 2021; the information requested in point (2) within two years from the date of publication of a guidance document on evaluation of isomer mixtures; and the information requested in point (3) within two years from the date of publication of a guidance document on evaluation of the effect of water treatment processes on the nature of residues present in surface and groundwater.

(iii) for the fifth paragraph there were substituted—

For the information requested in point (4), the applicant must submit an updated assessment of the information already submitted and, where relevant, further information to confirm the absence of androgenic endocrine activity by 30 October 2021.

(6) In this paragraph, “the Annex” has the meaning given in paragraph 2(5).

Existing approvals: supplementary

4

(1) When implementing the uniform principles as referred to in Article 29(6)(a) of Regulation (EC) No 1107/2009 for a plant protection product which contains an active substance, basic substance, low-risk active substance or candidate for substitution to which paragraph 2(1) applies, the competent authority must take into account the conclusions of the review report on that substance or candidate, and in particular Appendices 1 and 2 of that report.

(2) Each competent authority must make available on request a free copy of a review report for an active substance, basic substance, low-risk active substance or candidate for substitution to which paragraph 2(1) applies.

(3) Sub-paragraph (2) does not apply—

(a) to any confidential information within the meaning of Article 63 of Regulation (EC) No 1107/2009;

(b) otherwise, from the earliest of the following—

(i) the date on which the approval of that substance or candidate is renewed;

(ii) the date on which the approval of that substance or candidate is withdrawn or expires.

Existing candidates for substitution under Commission Implementing Regulation (EU) 2015/408

5

(1) An active substance which immediately before IP completion day is set out in the Annex to Commission Implementing Regulation (EU) 2015/408 on implementing Article 80(7) of Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market and establishing a list of candidates for substitution is taken to have been approved by each competent authority in relation to its constituent territory under Article 13 of Regulation (EC) No 1107/2009 as a candidate for substitution.

(2) Sub-paragraph (1) does not apply for the purposes of applications for plant protection products—

(a) which were submitted before 4th April 2018, where the plant protection product contains 8-hydroxyquinoline;

(b) otherwise, which were submitted before 1st August 2015.

Ongoing active substance approval applications

6

(1) This paragraph applies in relation to an application for approval of an active substance, or for amendment of the conditions of such an approval, where—

(a) before IP completion day , that application was submitted to the United Kingdom as rapporteur Member State under Article 7 of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day , and

(b) immediately before IP completion day , a Regulation adopted under Article 13(2) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day in relation to that application has not entered into force.

(2) An application in relation to which this paragraph applies is taken as being made on the day on which it was made—

(a) where the application is for approval of an active substance, under Article 7(1) of Regulation (EC) No 1107/2009;

(b) where the application is for amendment of the conditions of approval of an active substance, under Article 7(1A) of Regulation (EC) No 1107/2009.

(3) The relevant competent authority is the assessing competent authority for an application to which this paragraph applies.

(4) Anything done before IP completion day in relation to an application to which this paragraph applies—

(a) by the rapporteur Member State;

(b) by the European Food Safety Authority under Article 10 or 12 of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day ;

is taken to have been done by the relevant competent authority as the assessing competent authority.

(5) In sub-paragraphs (3) and (4), the “relevant competent authority” is the Secretary of State, subject to sub-paragraphs (6) to (8).

(6) The Secretary of State may appoint another competent authority as the relevant competent authority for an application to which this paragraph applies with the agreement of that competent authority.

(7) The relevant competent authority must notify the applicant following an appointment under sub-paragraph (6).

(8) An appointment in accordance with sub-paragraph (6) does not affect anything done by the Secretary of State as assessing competent authority prior to appointment.

(9) In this paragraph—

“assessing competent authority” has the same meaning as in Subsection 2 of Section 1 of Chapter 2 of Regulation (EC) No 1107/2009;

“rapporteur Member State” has the meaning given by Article 3(22) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day .

Ongoing active substance renewal applications

7

(1) This paragraph applies in relation to an application for renewal of the approval of an active substance where—

(a) before IP completion day , that application was submitted to the United Kingdom as rapporteur Member State or co-rapporteur Member State in accordance with Article 1 of Regulation (EU) No 844/2012 as it had effect immediately before IP completion day , and

(b) immediately before IP completion day a Regulation adopted under Article 20(1) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day in relation to that application has not entered into force.

(2) An application in relation to which this paragraph applies is taken as being made under Article 1 of Regulation (EU) No 844/2012 on the date on which it was made, and the relevant competent authority is the assessing competent authority for that application.

(3) Anything done before IP completion day in relation to an application to which this paragraph applies—

(a) by the rapporteur Member State or the United Kingdom as co-rapporteur Member State;

(b) by the European Food Safety Authority under Regulation (EU) No 844/2012 as it had effect immediately before IP completion day ;

is taken to have been done by the relevant competent authority as the assessing competent authority.

(4) In sub-paragraphs (2) and (3), the “relevant competent authority” is the Secretary of State subject to sub-paragraphs (5) to (7).

(5) The Secretary of State may appoint another competent authority as the relevant competent authority for an application to which this paragraph applies with the agreement of that competent authority.

(6) The relevant competent authority must notify the applicant following an appointment under sub-paragraph (5).

(7) An appointment in accordance with sub-paragraph (5) does not affect anything done by the Secretary of State as assessing competent authority prior to appointment.

(8) In this paragraph—

“assessing competent authority” has the meaning given by Article 15(1A) of Regulation (EC) No 1107/2009;

“co-rapporteur Member State” means the co-rapporteur Member State for the active substance which is the subject of the application as set out in the third column in the Annex to Commission Implementing Regulation (EU) No 686/2012 as it had effect immediately before IP completion day;

“rapporteur Member State” means the rapporteur Member State for the active substance which is the subject of the application as set out in the second column in the Annex to Commission Implementing Regulation (EU) No 686/2012 as it had effect immediately before IP completion day.

Requirement to provide existing maximum residue level applications in support of new active substance approval or renewal applications

8

(1) Sub-paragraph (2) applies where—

(a) on or after IP completion day an application is made—

(i) for approval of an active substance or the amendment of the conditions of such an approval in accordance with Article 7(1) or (1A) of Regulation (EC) No 1107/2009, or

(ii) for renewal of approval of an active substance in accordance with Article 15 of Regulation (EC) No 1107/2009, and

(b) before IP completion day a relevant application for a maximum residue level was made in accordance with Article 7 of Regulation (EC) No 396/2005 as it had effect immediately before IP completion day .

(2) Where this sub-paragraph applies, the obligation in Article 8(1)(g) of Regulation (EC) No 1107/2009 or Article 7(1)(i) of Regulation (EU) No 844/2012 (as the case may be) to provide a copy of a relevant application for a maximum residue level as referred to in Article 7 of Regulation (EC) No 396/2005 is to be read as including an obligation to provide a copy of the application described in sub-paragraph (1)(b).

PART 3 — Plant protection products

Ongoing plant protection product authorisation applications where a member State is examining the application under Article 35 of Regulation (EC) No 1107/2009

9

(1) This paragraph applies in relation to an application for authorisation to place a plant protection product on the market in the United Kingdom or the amendment of such an authorisation where—

(a) before IP completion day —

(i) that application was made in accordance with Article 33 of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day ,

(ii) a member State or EEA state had agreed to examine that application in accordance with the first paragraph of Article 35 of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day , and

(b) immediately before IP completion day a decision to grant or refuse the application had not been made by a competent authority in accordance with Article 36(2) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day .

(2) An application in relation to which this paragraph applies is taken to have been made in accordance with Article 33 of Regulation (EC) No 1107/2009—

(a) where the member State or EEA state described in sub-paragraph (1)(a)(ii) had made its assessment available to the United Kingdom before IP completion day in accordance with the third subparagraph of Article 36(1) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day , on the date on which the application was made,

(b) otherwise, on IP completion day .

(3) Where sub-paragraph (2)(a) applies to an application, anything done by the member State or EEA state in respect of the examination of the application before IP completion day is taken to have been done by a competent authority.

(4) In this paragraph, a reference to an Article of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day in respect of an EEA state means that Article as adapted by the EEA agreement as it had effect immediately before IP completion day .

Requirement to provide existing maximum residue level applications in support of new plant protection product authorisation applications

10

(1) Sub-paragraph (2) applies where—

(a) on or after IP completion day an application is made for authorisation of a plant protection product or amendment of such an authorisation in accordance with Article 33 of Regulation (EC) No 1107/2009, and

(b) before IP completion day a relevant application for a maximum residue level was made in accordance with Article 7 of Regulation (EC) No 396/2005 as it had effect immediately before IP completion day .

(2) Where this sub-paragraph applies, the obligation in Article 33(3)(e) of Regulation (EC) No 1107/2009 to provide a copy of a relevant application for a maximum residue level as referred to in Article 7 of Regulation (EC) No 396/2005 is to be read as including an obligation to provide a copy of the application described in sub-paragraph (1)(b).

Assessment of equivalence under Article 38(1) of Regulation (EC) No 1107/2009 where active substance last approved before IP completion day

11

(1) Sub-paragraph (2) applies where—

(a) it is necessary to assess equivalence of an active substance in accordance with Article 38 of Regulation (EC) No 1107/2009, and

(b) the active substance was last approved before IP completion day in accordance with Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day .

(2) Where this sub-paragraph applies, the assessing competent authority for the purposes of Article 38 of Regulation (EC) No 1107/2009 is the Secretary of State, subject to sub-paragraphs (3) to (5).

(3) The Secretary of State may appoint another competent authority as the assessing competent authority for the purposes of Article 38 of Regulation (EC) No 1107/2009.

(4) The assessing competent authority must notify the applicant for the authorisation of the plant protection product to which the assessment of equivalence relates following an appointment under sub-paragraph (3).

(5) An appointment in accordance with sub-paragraph (3) does not affect anything done by the Secretary of State as assessing competent authority prior to that appointment.

Compliance checks or assessment of information under Article 43(3) of Regulation (EC) No 1107/2009 where product examined before IP completion day

12

(1) Sub-paragraph (2) applies where—

(a) it is necessary to complete compliance checks of a plant protection product or assess information relating to the renewal of that product in accordance with Article 43(3) of Regulation (EC) No 1107/2009, and

(b) before IP completion day a member State or EEA state examined the application for that plant protection product in accordance with the first paragraph of Article 35 of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day .

(2) Where this sub-paragraph applies, the competent authority which examined the application for the purposes of Article 43(3) of Regulation (EC) No 1107/2009 is taken to be the Secretary of State.

(3) In sub-paragraph (1)(b), the reference to Article 35 of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day in relation to an EEA state means that Article as adapted by the EEA agreement as it had effect immediately before IP completion day .

Ongoing evaluations under Article 56(3) of Regulation (EC) No 1107/2009

13

(1) Sub-paragraph (2) applies where—

(a) before IP completion day the holder of an authorisation of a plant protection product had notified a competent authority in accordance with Article 56(1) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day ,

(b) in accordance with the first subparagraph of Article 56(3) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day , a member State or EEA state was obliged to evaluate the information received, and

(c) immediately before IP completion day that member State or EEA state had not informed the competent authority in accordance with the first or second subparagraph of Article 56(3) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day .

(2) Where this sub-paragraph applies, the first subparagraph of Article 56(3) of Regulation (EC) No 1107/2009 applies in respect of that notification as if the reference to the competent authority which first granted the authorisation were a reference to the competent authority referred to in sub-paragraph (1)(a) of this paragraph.

(3) In sub-paragraph (1)(b) and (c), the reference to Article 56(3) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day in relation to an EEA state means that Article as adapted by the EEA agreement as it had effect immediately before IP completion day .

PART 4 — Treated seeds

Treated seeds

14

(1) Article 49(1) of Regulation (EC) No 1107/2009 applies to seeds to which sub-paragraph (2) applies as it applies to seeds to which Article 49(1) applies.

(2) This sub-paragraph applies to—

(a) seeds treated before IP completion day with a plant protection product which at the time of treatment was authorised for that use in at least one member State or EEA state but not in Great Britain;

(b) seeds treated on or after IP completion day with a plant protection product which immediately before IP completion day was authorised for that use in at least one member State or EEA state but not in Great Britain.

(3) But sub-paragraph (2) does not apply to the extent that immediately before IP completion day the sale or use of such seeds was restricted or prohibited by measures adopted in Great Britain or by the European Commission in accordance with Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day (as adapted by the EEA agreement as it had effect immediately before IP completion day).

(4) Sub-paragraphs (1) and (3) cease to have effect in respect of seeds to which sub-paragraph (2) applies in relation to a constituent territory on the earliest of the following dates—

(a) the date on which the plant protection product used to treat the seeds is no longer authorised for that use in at least one member State or EEA state;

(b) 1st July 2027.

(5) In this paragraph, “EEA state” does not include the Principality of Liechtenstein.

PART 5 — Existing guidance

Existing guidance

15

(1) Sub-paragraph (2) applies to a guidance document which relates to Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day , where—

(a) before IP completion day , the guidance document was noted by the Committee, and

(b) immediately before IP completion day , that guidance document had not been withdrawn or replaced.

(2) A guidance document to which this sub-paragraph applies is taken to have been issued by each competent authority in relation to its constituent territory in accordance with Article 77(1) of Regulation (EC) No 1107/2009.

(3) Where the guidance document to which sub-paragraph (2) applies relates to scientific methods referred to in Article 4(2)(a) or (3)(b) or (e) of Regulation (EC) No 1107/2009, those methods are taken to have been accepted by each competent authority in accordance with Article 4(8).

(4) In sub-paragraph (1)(a), “the Committee” means the Standing Committee described in Article 79(1) of Regulation (EC) No 1107/2009 as it had effect immediately before IP completion day .

SCHEDULE 2 — Revocations

PART 1 — Regulations

1

Commission Regulation (EEC) No 3600/92 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market.

2

Commission Regulation (EC) No 933/94 laying down the active substances of plant protection products and designating the rapporteur Member States for the implementation of Commission Regulation (EEC) No 3600/92.

3

Commission Regulation (EC) No 491/95 amending Regulation (EEC) No 3600/92 and Regulation (EC) No 933/94, in particular with regard to the integration of the designated public authorities and the producers in Austria, Finland and Sweden in the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market.

4

Commission Regulation (EC) No 2230/95 amending Regulation (EC) No 933/94 laying down the active substances of plant protection products and designating the rapporteur Member States for the implementation of Commission Regulation (EEC) No 3600/92.

5

Commission Regulation (EC) No 1199/97 amending Regulation (EEC) No 3600/92 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market.

6

Commission Regulation (EC) No 1972/1999 amending Regulation (EEC) No 3600/92 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market.

7

Commission Regulation (EC) No 451/2000 laying down the detailed rules for the implementation of the second and third stages of the work programme referred to in Article 8(2) of Council Directive 91/414/EEC.

8

Commission Regulation (EC) No 2266/2000 amending Regulation (EEC) No 3600/92 laying down the detailed rules for the implementation of the first stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market.

9

Commission Regulation (EC) No 703/2001 laying down the active substances of plant protection products to be assessed in the second stage of the work programme referred to in Article 8(2) of Council Directive 91/414/EEC and revising the list of Member States designated as rapporteurs for those substances.

10

Commission Regulation (EC) No 1490/2002 laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and amending Regulation (EC) No 451/2000.

11

Commission Regulation (EC) No 1044/2003 amending Regulations (EC) No 451/2000 and (EC) No 1490/2002.

12

Commission Regulation (EC) No 1336/2003 amending Regulation (EC) No 2076/2002 as regards the continued use of the substances listed in Annex II.

13

Commission Regulation (EC) No 771/2004 laying down transitional measures with regard to continued use of plant protection products containing certain active substances following the accession of new Member States to the European Union.

14

Commission Regulation (EC) No 835/2004 adapting Regulation (EC) No 2076/2002 and Decisions 2002/928/EC, 2004/129/EC, 2004/247/EC and 2004/248 as regards the continued use of certain active substances not included in Annex I to Directive 91/414/EEC, by reason of the accession of the Czech Republic, Estonia, Cyprus, Latvia, Lithuania, Hungary, Malta, Poland, Slovenia and Slovakia.

15

Commission Regulation (EC) No 1744/2004 amending Regulation (EC) No 1490/2002 as regards the replacement of a rapporteur Member State.

16

Commission Regulation (EC) No 1765/2004 amending Regulation (EC) No 2076/2002 as regards the continued use of the substances listed in Annex II.

17

Commission Regulation (EC) No 2229/2004 laying down further detailed rules for the implementation of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC.

18

Commission Regulation (EC) 1335/2005 amending Regulation (EC) No 2076/2002 and Decisions 2002/928/EC, 2004/129/EC, 2004/140/EC, 2004/247/EC and 2005/303/EC as regards the time period referred to in Article 8(2) of Council Directive 91/414/EEC and the continued use of certain substances not included in its Annex I.

19

Commission Regulation (EC) No 1980/2006 laying down transitional measures amending Regulation (EC) No 2076/2002 and Decisions 2001/245/EC, 2002/928/EC and 2006/797/EC as regards the continued use of certain active substances not included in Annex I to Directive 91/414/EC by reason of the accession of Bulgaria.

20

Commission Regulation (EC) No 2024/2006 laying down transitional measures derogating from Regulation (EC) No 2076/2002 and Decisions 98/270/EC, 2002/928/EC, 2003/308/EC, 2004/129/EC, 2004/141/EC, 2004/247/EC, 2004/248/EC, 2005/303/EC and 2005/864/EC as regards the continued use of plant protection products containing certain active substances not included in Annex I to Directive 91/414/EC by reason of the accession of Romania.

21

Commission Regulation (EC) No 647/2007 amending Regulation (EC) No 2229/2004 laying down further detailed rules for the implementation of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC.

22

Commission Regulation (EC) No 737/2007 on laying down the procedure for the renewal of the inclusion of a first group of active substances in Annex I to Council Directive 91/414/EEC and establishing the list of those substances.

23

Commission Regulation (EC) No 1095/2007 amending Regulation (EC) No 1490/2002 laying down further detailed rules for the implementation of the third stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC and Regulation (EC) No 2229/2004 laying down further detailed rules for the implementation of the fourth stage of the programme of work referred to in Article 8(2) of Council Directive 91/414/EEC.

24

Commission Regulation (EC) No 1313/2007 amending Regulations (EC) No 2076/2002 as regards the extension of the time period referred to in Article 8(2) of Council Directive 91/414/EEC with respect to metalaxyl and (EC) No 2024/2006 as regards the deletion of the derogation concerning metalaxyl.

25

Commission Regulation (EC) No 33/2008 laying down detailed rules for the application of Council Directive 91/414/EEC as regards a regular and an accelerated procedure for the assessment of active substances which were part of the programme of work referred to in Article 8(2) of that Directive but have not been included into its Annex I.

26

Commission Regulation (EC) No 416/2008 amending Regulation (EEC) No 3600/92 as regards the assessment of the active substance metalaxyl in the framework of Article 8(2) of Council Directive 91/414/EEC concerning the placing of plant protection products on the market.

27

Commission Regulation (EC) No 848/2008 amending Regulation (EC) No 2076/2002 and Decision 2003/565/EC as regards the time period provided for in Article 8(2) of Council Directive 91/414/EEC.

28

Commission Regulation (EU) No 78/2010 amending Regulation (EC) No 33/2008 as regards the scope and the period granted under the regular procedure to the Authority for the adoption of its conclusions concerning the inclusion of certain active substances in Annex I to Directive 91/414/EEC.

29

Commission Regulation (EU) No 114/2010 amending Regulation (EC) No 2229/2004 as regards the time period granted to EFSA for the delivery of its view on the draft review reports concerning the active substances for which there are clear indications that they do not have any harmful effects.

30

Commission Regulation (EU) No 741/2010 amending Regulations (EC) No 1490/2002 and (EC) No 2229/2004 as regards the date until which authorisations may continue to be in force at 31.12.2020 in cases where the notifier has submitted an application in accordance with the accelerated procedure under Regulation (EC) No 33/2008.

31

Commission Implementing Regulation (EU) No 540/2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances.

32

Commission Implementing Regulation (EU) No 541/2011 amending Implementing Regulation (EU) No 540/2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances.

33

Commission Implementing Regulation (EU) No 542/2011 amending Implementing Regulation (EU) No 540/2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances to take into account Directive 2011/58/EU amending Council Directive 91/414/EEC to renew the inclusion of carbendazim as active substance.

34

Commission Implementing Regulation (EU) No 702/2011 approving the active substance prohexadione, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

35

Commission Implementing Regulation (EU) No 703/2011 approving the active substance azoxystrobin, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

36

Commission Implementing Regulation (EU) No 704/2011 approving the active substance azimsulfuron, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

37

Commission Implementing Regulation (EU) No 705/2011 approving the active substance imazalil, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

38

Commission Implementing Regulation (EU) No 706/2011 approving the active substance profoxydim, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

39

Commission Implementing Regulation (EU) No 736/2011 approving the active substance fluroxypyr, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

40

Commission Implementing Regulation (EU) No 740/2011 approving the active substance bispyribac, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

41

Commission Implementing Regulation (EU) No 786/2011 approving the active substance 1-naphthylacetamide, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/941/EC.

42

Commission Implementing Regulation (EU) No 787/2011 approving the active substance 1-naphthylacetic acid, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and Commission Decision 2008/941/EC.

43

Commission Implementing Regulation (EU) No 788/2011 approving the active substance fluazifop-P, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011and Commission Decision 2008/934/EC.

44

Commission Implementing Regulation (EU) No 797/2011 approving the active substance spiroxamine, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011.

45

Reading this document does not replace reading the official text published on legislation.gov.uk. Contains public sector information licensed under the Open Government Licence v3.0. We assume no responsibility for any inaccuracies arising from the conversion of the original CLML XML to this format.

This text is published under legislation.gov.uk's own terms of reuse, not a Legalize or public-domain licence. legislation.gov.uk
Open Government Licence v3.0 (attribution required)
© Crown and database right. Derived from content available under the Open Government Licence v3.0 from legislation.gov.uk.